Diagnostic performance of sixteen biomarkers for MASLD: A study in a Mexican cohort [0.03%]
用于诊断MASLD的16种生物标志物的诊断性能：墨西哥队列研究
Bryan Adrian Priego-Parra,Sara Alejandra Reyes-Diaz,Héctor Ricardo Ordaz-Alvarez et al.
Bryan Adrian Priego-Parra et al.
Background and aims: Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) poses a heightened cardiovascular risk. Identifying efficient biomarkers for early MASLD detection in resource-limited Latin American r...
Selective inner muscle layer myotomy is associated with lower pain and same clinical efficacy that full-thickness myotomy in patients treated by POEM for achalasia: A multicenter retrospective comparative analysis of 158 patients [0.03%]
选择性内肌层切开与全层切开的POEM治疗贲门失迟缓症的有效性和术后疼痛的多中心回顾性分析：158例患者的比较研究
Mathilde Sanavio,Blandine Vauquelin,Marie-Christine Picot et al.
Mathilde Sanavio et al.
Introduction: The aim of this study was to compare the impact of the depth of myotomy (selective inner layer myotomy (SIM) vs. full-thickness myotomy (FTM)) on the outcome of patients treated with POEM for achalasia. ...
Efficacy of rituximab-containing regimens used as first-line and rescue therapy for giant cell hepatitis with autoimmune hemolytic anemia a retrospective study [0.03%]
利妥昔单抗一线及挽救治疗巨细胞型肝炎合并自身免疫性溶血性贫血疗效的回顾分析
Xue-Yuan Zhang,Jing-Yu Gong,Jian-She Wang et al.
Xue-Yuan Zhang et al.
Objective: To evaluate the efficacy of rituximab (RTX)-containing therapy as first-line as well as rescue treatment for giant cell hepatitis with autoimmune hemolytic anemia (GCH-AHA). ...
Clinical improvement effect of regulating gut microbiota on metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis of randomized controlled trials [0.03%]
调节肠道微生态改善代谢功能障碍相关脂肪肝的临床疗效：系统评价和Meta分析
Juan Wu,Xiaoyang Chen,Jun Qian et al.
Juan Wu et al.
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is constantly rising globally. There are barely any effective medications or supplements for the management of MASLD. We aim to systematically e...
Higher risk of in-hospital mortality and hepatic encephalopathy during weekend admission in Transjugular Intrahepatic Portosystemic Shunt procedure [0.03%]
经颈静脉肝内门体分流术择期周末住院的院内死亡率和肝性脑病的风险更高
Renxi Li,SeungEun Lee,William Rienas et al.
Renxi Li et al.
Objectives: Transjugular intrahepatic portosystemic shunt (TIPS) is a procedure used to alleviate portal hypertension in patients with decompensated liver cirrhosis. The weekend effect refers to a higher risk of adverse o...
Clinical significance of lncRNA XIST expression in cholangiocarcinoma and its effect on cell migration and invasion [0.03%]
长链非编码RNA XIST在胆管癌中的临床意义及其对细胞迁移和侵袭的影响研究
Chenxi Li,Yifei Dong,Yichuan Zhang et al.
Chenxi Li et al.
Background: Cholangiocarcinoma is a malignant tumor that occurs in the bile duct system, and the prognosis of patients is poor. Currently, research suggests that long non-coding RNAs (lncRNAs) in the treatment and prevent...
Hepatitis B virus-associated hepatocellular carcinoma with invasion into right atrium [0.03%]
侵及右心房的乙肝病毒相关肝细胞癌
Qiong Wang,Wei Liu,Jeffrey V Esteron
Qiong Wang
The pan immune inflammatory value in relation to non-alcoholic fatty liver disease and hepatic fibrosis [0.03%]
与非酒精性脂肪肝病和肝脏纤维化相关的全身免疫炎症价值
Rong Jiang,Yunfeng Hua,Xiang Hu et al.
Rong Jiang et al.
Background: Inflammation played a critical role in non-alcoholic fatty liver disease (NAFLD). Here, we aimed to explore the relationship between inflammatory biomarkers and the prevalence of NAFLD and hepatic fibrosis in ...
Exploring the role of mitochondrial proteins SIRT5 and MRPL33 through Mendelian randomization in primary biliary cholangitis [0.03%]
孟德尔随机化研究线粒体蛋白SIRT5和MRPL33在原发性胆汁性肝硬化的中作用探索
Jingqin Hu,Yuqiang Mi,Li Wang et al.
Jingqin Hu et al.
Background: Primary biliary cholangitis (PBC) is an autoimmune liver disease characterized by elevated serum antimitochondrial antibody levels in 90-95 % of cases. However, the exact causal relationship between mitochondr...
Crigler Najjar syndrome type II with severe jaundice as a new subtype(?) : A rare case report [0.03%]
克里格勒-纳贾尔综合征Ⅱ型伴严重黄疸亚型1例报告
Xinqi Li,Dechun Wang,Ruobing Li et al.
Xinqi Li et al.